Latest Breaking News On - Cutaneous oncology - Page 6 : vimarsana.com

LISTEN: Jimmy Buffett Died of 'Rare' Skin Cancer | Magic 107.7

Merkel, the skin cancer that attacked Jimmy Buffett, is rare but aggressive

Addition of Navitoclax to Dabrafenib/Trametinib Aims to Improve Efficacy of Targeted Therapy in BRAF+ Metastatic Melanoma

Zeynep Eroglu, MD, explains the rationale for adding navitoclax to dabrafenib plus trametinib in the treatment of patients with BRAF V600–mutant metastatic melanoma, highlights the methodologies and results of the CTEP-P9466 trial, and describes the implications of this research for this patient population.

Palvella Therapeutics Announces Planned Pivotal Phase 3 Study Design of QTORIN™ 3.9% Rapamycin ...

QTORIN™ rapamycin has potential to become first approved therapy and standard of care for Microcystic Lymphatic Malformations in U.S.; significant commercial opportunity based on an estimated more than 30,000 individuals

WMNF | Doctor emphasizes screening and safety measures as Floridians face higher risk of skin cancer

WMNF’s Chris Young speaks with a Florida doctor about the importance of skin safety getting screened as sunny weather is here.